These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2804301)

  • 1. [Characteristics of the action of cisplatin and cycloplatam on the rat kidney].
    Natochin IuV; Reznik LV; Brovtsyn VK; Ivanov VB; Miazina EM; Chel'tsov PA; Shakhmatova EI
    Biull Eksp Biol Med; 1989 Jul; 108(7):52-4. PubMed ID: 2804301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study of the action of antineoplastic platinum compounds with varying nephrotoxic effects].
    Bakhteeva VT; Fok EM; Lavrova EA
    Vopr Med Khim; 1996; 42(4):301-6. PubMed ID: 9254514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of anti-tumor agents cisplatin and cycloplatam on membrane protein kinase C activity in murine T-lymphocytes].
    Khabarov SV; Gerasimova GK
    Biokhimiia; 1996 Oct; 61(10):1866-73. PubMed ID: 9011234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental study of renal disorder caused by oxaliplatin in rat renal cortical slices.
    Kanou T; Uozumi J; Soejima K; Tokuda Y; Masaki Z
    Clin Exp Nephrol; 2004 Dec; 8(4):310-5. PubMed ID: 15619029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Morphofunctional correlates of the nephrotoxic action of cis-platin].
    Bakhteeva VT; Vinnichenko LN; Gambarian SP; Miazina EM; Natochin IuV
    Arkh Patol; 1987; 49(3):48-54. PubMed ID: 3593006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative nephrotoxicity of cisplatin and new octahedral Pt(IV) complexes.
    Kim WK; Kwon YE
    Cancer Chemother Pharmacol; 2007 Jul; 60(2):237-43. PubMed ID: 17089165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of prednisolone for the attenuation of the nephrotoxic effect of cisplatin].
    Bakhteeva VT; Karpenko LA
    Eksp Klin Farmakol; 1994; 57(4):55-8. PubMed ID: 7950789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of cisplatin-induced carnitine deficiency and energy starvation by propionyl-L-carnitine in rat kidney tissues.
    Aleisa AM; Al-Majed AA; Al-Yahya AA; Al-Rejaie SS; Bakheet SA; Al-Shabanah OA; Sayed-Ahmed MM
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1252-9. PubMed ID: 17973863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ontogenic aspects of cisplatin-induced nephrotoxicity in rats.
    Ali BH; Al-Moundhri M; Tageldin M; Al Husseini IS; Mansour MA; Nemmar A; Tanira MO
    Food Chem Toxicol; 2008 Nov; 46(11):3355-9. PubMed ID: 18790000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oxoplatinum and CBDCA on renal functions in rats.
    Láznícková A; Semecký V; Láznícek M; Zubr V; Koksál J; Kvĕtina J
    Neoplasma; 1989; 36(2):161-9. PubMed ID: 2654665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnesium depletion enhances cisplatin-induced nephrotoxicity.
    Lajer H; Kristensen M; Hansen HH; Nielsen S; Frøkiaer J; Ostergaard LF; Christensen S; Daugaard G; Jonassen TE
    Cancer Chemother Pharmacol; 2005 Nov; 56(5):535-42. PubMed ID: 15947931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice.
    Hirose A; Sato E; Fujii H; Sun B; Nishioka H; Aruoma OI
    Toxicol Appl Pharmacol; 2007 Jul; 222(2):152-8. PubMed ID: 17555784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats.
    Uehara T; Watanabe H; Itoh F; Inoue S; Koshida H; Nakamura M; Yamate J; Maruyama T
    Arch Toxicol; 2005 Aug; 79(8):451-60. PubMed ID: 15856183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplacental passage of Pt after treatment with the new triamine complex cis-diaminechloro-[2-(diethylamino) ethyl 4-amino-benzoate, N4]-chloride platinum (II) monohydrochloride monohydrate.
    Ognio E; Chiavarina B; Caviglioli G; Lapide M; Viale M
    Arch Toxicol; 2004 Oct; 78(10):584-8. PubMed ID: 15150682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of a palladium(II)-dithiocarbamate complex: biological assay and nephrotoxicity in rats.
    Trevisan A; Marzano C; Cristofori P; Borella Venturini M; Giovagnini L; Fregona D
    Arch Toxicol; 2002 Jun; 76(5-6):262-8. PubMed ID: 12107643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biochemical mechanisms of resistance to a new antineoplastic agent amin(cyclopeptidylamin)-S-(-)-malatoplatinum (II) (cycloplatam)].
    Dederer LIu; Lankin VZ; Konovalova AL; Gorbacheva LB
    Biokhimiia; 1995 Apr; 60(4):602-9. PubMed ID: 7779982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors.
    Dominguez MF; Macias RI; Izco-Basurko I; de La Fuente A; Pascual MJ; Criado JM; Monte MJ; Yajeya J; Marin JJ
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1106-12. PubMed ID: 11356935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of L-arginine against cisplatin-induced renal oxidative stress and toxicity: role of nitric oxide.
    Saleh S; El-Demerdash E
    Basic Clin Pharmacol Toxicol; 2005 Aug; 97(2):91-7. PubMed ID: 15998355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the anticancer dehydrotarplatin on cytochrome P450 and antioxidant enzymes in male rat tissues.
    Nannelli A; Messina A; Marini S; Trasciatti S; Longo V; Gervasi PG
    Arch Toxicol; 2007 Jul; 81(7):479-87. PubMed ID: 17364183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.